SJS Investment Consulting’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.7K Buy
97
+89
+1,113% +$3.73K ﹤0.01% 1333
2026
Q1
$258 Buy
8
+2
+33% +$74 ﹤0.01% 1929
2025
Q4
$253 Buy
6
+4
+200% +$161 ﹤0.01% 1735
2025
Q3
$69 Sell
2
-2
-50% -$57 ﹤0.01% 1592
2025
Q2
$109 Sell
4
-6
-60% -$174 ﹤0.01% 1476
2025
Q1
$297 Hold
10
﹤0.01% 1384
2024
Q4
$396 Buy
10
+6
+150% +$227 ﹤0.01% 1322
2024
Q3
$137 Hold
4
﹤0.01% 1549
2024
Q2
$87 Sell
4
-1
-20% -$21 ﹤0.01% 1588
2024
Q1
$111 Buy
5
+2
+67% +$49 ﹤0.01% 1562
2023
Q4
$83 Sell
3
-1
-25% -$24 ﹤0.01% 1567
2023
Q3
$90 Sell
4
-1
-20% -$26 ﹤0.01% 1555
2023
Q2
$128 Buy
5
+4
+400% +$97 ﹤0.01% 1477
2023
Q1
$23 Buy
+1
New +$24 ﹤0.01% 1559

Other funds holding VCYT

SJS Investment Consulting's VCYT Position: Q2 2026 in Review

SJS Investment Consulting increased its Veracyte (VCYT) stake by 1,113% in Q2 2026, buying an estimated $3.73K and bringing the position to 97 shares worth $5.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

SJS Investment Consulting first reported a position in VCYT in Q1 2023 and has held it in 14 quarters since. 162 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • SJS Investment Consulting held 97 shares of Veracyte worth $5.7K as of Q2 2026.
  • SJS Investment Consulting bought 89 Veracyte shares in Q2 2026, an estimated $3.73K.
  • Veracyte made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1333 holding.
  • SJS Investment Consulting first reported a position in Veracyte in Q1 2023 and has held it in 14 quarters since.
  • 162 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.